S 998 · in committee · significant
Medical Supply Chain Resiliency Act
- economy
What this bill does
- The bill lets the President negotiate trade agreements with other countries to reduce barriers on medical devices and pharmaceuticals.
- Medical manufacturers, pharmaceutical companies, and countries that trade medical goods are affected by these agreements.
- The President must notify Congress 60 days before negotiating, and Congress can block agreements with a disapproval resolution.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would allowing the President to negotiate trade agreements on medical devices and pharmaceuticals affect drug prices for American consumers?
- 02
What oversight mechanisms does the 60-day notification period and Congressional disapproval process provide, and are they sufficient?
- 03
Which countries or trading partners would likely benefit most from reduced trade barriers on medical goods under this framework?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-NC
Thom Tillis
Citizen cosponsors
0
In Congress
3/ 100
Senators cosponsoring
Introduced 2025-03-12
Joining the bill
Legislative timeline
2025-03-12 · senate · IntroReferral
Read twice and referred to the Committee on Finance.
2025-03-12 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.